Oridermyl: The dosage of Triamcinolone acetonide may be out of specification for the affected lots.
Brand(s)
Last updated
Summary
Product
Oridermyl
Issue
Health products - Product safety
What to do
Consult your health care professional if you have any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
Oridermyl |
Oridermyl |
DIN 02364166 |
Ointment |
Neomycin Sulfate 3500 unit/G, Nystatin 100000 unit/G, Permethrin 10mg/g, Triamcinolone Acetonide 1mg/g |
2C1103E, 2C1103G, 2C2544G |
Issue
The dosage of Triamcinolone acetonide may be out of specification for the affected lots.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recalls: Wholesalers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Veterinary drugs
Companies
Vetoquinol N.-A. Inc.
2000 chemin Georges,
Lavaltrie, Quebec,
J5T 3S5
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type III
Identification number
RA-76603
Get notified
Receive notifications for new and updated recalls and alerts by category.